Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alere Inc. stock logo
ALR
Alere
$1.32
$0.00
$34.41
$51.00
$43.05M0.8540,839 shsN/A
National HealthCare Co. stock logo
NHC
National HealthCare
$106.35
-2.3%
$102.22
$89.14
$137.53
$1.65B0.5859,733 shs41,827 shs
Profound Medical stock logo
PROF
Profound Medical
$5.54
+1.7%
$5.93
$3.89
$9.87
$163.79M0.5223,879 shs40,532 shs
Instil Bio, Inc. stock logo
TIL
Instil Bio
$28.25
+4.7%
$27.76
$9.90
$92.00
$176.89M2.16170,842 shs94,451 shs
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alere Inc. stock logo
ALR
Alere
0.00%0.00%0.00%0.00%0.00%
National HealthCare Co. stock logo
NHC
National HealthCare
-2.27%+10.31%+9.20%-2.08%-15.44%
Profound Medical stock logo
PROF
Profound Medical
+1.65%-2.29%-2.81%+17.62%-40.49%
Instil Bio, Inc. stock logo
TIL
Instil Bio
+4.75%+8.91%+18.35%+93.10%+170.08%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Alere Inc. stock logo
ALR
Alere
N/AN/AN/AN/AN/AN/AN/AN/A
National HealthCare Co. stock logo
NHC
National HealthCare
N/AN/AN/AN/AN/AN/AN/AN/A
Profound Medical stock logo
PROF
Profound Medical
2.691 of 5 stars
3.51.00.00.03.42.50.6
Instil Bio, Inc. stock logo
TIL
Instil Bio
3.1147 of 5 stars
3.54.00.00.01.13.30.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Alere Inc. stock logo
ALR
Alere
0.00
N/AN/AN/A
National HealthCare Co. stock logo
NHC
National HealthCare
0.00
N/AN/AN/A
Profound Medical stock logo
PROF
Profound Medical
3.00
Buy$11.0098.56% Upside
Instil Bio, Inc. stock logo
TIL
Instil Bio
3.00
Buy$119.00321.24% Upside

Current Analyst Ratings Breakdown

Latest ALR, NHC, PROF, and TIL Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/5/2025
Instil Bio, Inc. stock logo
TIL
Instil Bio
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$125.00 ➝ $125.00
6/2/2025
Instil Bio, Inc. stock logo
TIL
Instil Bio
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform ➝ Market Perform
5/22/2025
Instil Bio, Inc. stock logo
TIL
Instil Bio
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$110.00 ➝ $105.00
(Data available from 8/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Alere Inc. stock logo
ALR
Alere
$934.59M0.05N/AN/A$5.72 per share0.23
National HealthCare Co. stock logo
NHC
National HealthCare
$1.46B1.13$6.78 per share15.68$59.41 per share1.79
Profound Medical stock logo
PROF
Profound Medical
$10.68M15.59N/AN/A$2.01 per share2.76
Instil Bio, Inc. stock logo
TIL
Instil Bio
N/AN/AN/AN/A$25.96 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Alere Inc. stock logo
ALR
Alere
-$29.92M-$1.20N/AN/AN/A-5.34%-20.78%-9.02%N/A
National HealthCare Co. stock logo
NHC
National HealthCare
$66.80M$6.7113.33N/A10.03%6.87%4.68%N/A
Profound Medical stock logo
PROF
Profound Medical
-$27.82M-$1.22N/AN/AN/A-269.35%-70.41%-57.22%N/A
Instil Bio, Inc. stock logo
TIL
Instil Bio
-$74.14M-$11.97N/AN/AN/AN/A-51.67%-32.77%N/A

Latest ALR, NHC, PROF, and TIL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2025Q2 2025
Profound Medical stock logo
PROF
Profound Medical
-$0.43-$0.52-$0.09-$0.52$4.75 million$2.21 million
8/13/2025Q2 2025
Instil Bio, Inc. stock logo
TIL
Instil Bio
-$1.72-$3.24-$1.52-$3.24N/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Alere Inc. stock logo
ALR
Alere
N/AN/AN/AN/AN/A
National HealthCare Co. stock logo
NHC
National HealthCare
$2.562.41%N/A38.15%10 Years
Profound Medical stock logo
PROF
Profound Medical
N/AN/AN/AN/AN/A
Instil Bio, Inc. stock logo
TIL
Instil Bio
N/AN/AN/AN/AN/A

Latest ALR, NHC, PROF, and TIL Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/8/2025
National HealthCare Co. stock logo
NHC
National HealthCare
quarterly$0.642.5%9/30/20259/30/202510/31/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Alere Inc. stock logo
ALR
Alere
0.45
1.58
1.58
National HealthCare Co. stock logo
NHC
National HealthCare
0.14
1.80
1.77
Profound Medical stock logo
PROF
Profound Medical
0.09
11.31
10.03
Instil Bio, Inc. stock logo
TIL
Instil Bio
0.58
30.33
30.33

Institutional Ownership

CompanyInstitutional Ownership
Alere Inc. stock logo
ALR
Alere
24.08%
National HealthCare Co. stock logo
NHC
National HealthCare
56.44%
Profound Medical stock logo
PROF
Profound Medical
47.86%
Instil Bio, Inc. stock logo
TIL
Instil Bio
60.56%

Insider Ownership

CompanyInsider Ownership
Alere Inc. stock logo
ALR
Alere
8.40%
National HealthCare Co. stock logo
NHC
National HealthCare
14.97%
Profound Medical stock logo
PROF
Profound Medical
1.52%
Instil Bio, Inc. stock logo
TIL
Instil Bio
47.20%
CompanyEmployeesShares OutstandingFree FloatOptionable
Alere Inc. stock logo
ALR
Alere
10,40032.61 million29.87 millionOptionable
National HealthCare Co. stock logo
NHC
National HealthCare
12,40015.50 million13.32 millionN/A
Profound Medical stock logo
PROF
Profound Medical
15030.05 million29.60 millionOptionable
Instil Bio, Inc. stock logo
TIL
Instil Bio
4106.56 million3.46 millionNo Data

Recent News About These Companies

Instil Bio Reports Promising Phase 2 Study Results
Instil Bio appoints new Chief Medical Officer

Media Sentiment Over Time

Top Headlines

View All Headlines
Alere stock logo

Alere NYSE:ALR

Alere Inc. is a provider of health information through diagnostic tests. The Company's segments include professional diagnostics, consumer diagnostics, and corporate and other. The professional diagnostics segment includes an array of diagnostic test products and other in vitro diagnostic tests marketed to medical professionals and laboratories for detection of diseases and conditions within its areas of focus. The consumer diagnostics segment consists primarily of manufacturing operations related to its role as the exclusive manufacturer of products for SPD Swiss Precision Diagnostics (SPD), its joint venture with The Procter & Gamble Company (P&G). The Company's professional diagnostic solutions allow patients and their healthcare providers to work together to manage patients' conditions over the continuum of care, from the hospital to home. The Company offers lines of drugs-of-abuse tests, reagent systems and laboratory testing options.

National HealthCare stock logo

National HealthCare NYSE:NHC

$106.35 -2.47 (-2.27%)
As of 08/14/2025 04:00 PM Eastern

National HealthCare Corporation engages in the operation of services to skilled nursing facilities, assisted and independent living facilities, homecare and hospice agencies, and health hospitals. Its skilled nursing facilities offer licensed therapy services, nutrition services, social services, activities, and housekeeping and laundry services, as well as medical services prescribed by physicians; and rehabilitative services, such as physical, speech, respiratory, and occupational therapy for patients recovering from strokes, heart attacks, orthopedic conditions, neurological illnesses, or other illnesses, injuries, or disabilities. The company's medical specialty units comprise memory care units and sub-cute nursing units that provide specialized care and programs for persons with Alzheimer's or related disorders; and assisted living facilities offer personal care services and assistance with general activities of daily living, such as dressing, bathing, meal preparation, and medication management. Its independent living facilities offers specially designed residential units for the active and ambulatory elderly and provide various ancillary services for residents, including restaurants, activity rooms and social areas; and behavioral health services to both adults and geriatric patients with psychiatric, emotional, and addictive disorders. In addition, the company's homecare agencies assist those who wish to stay at home or in assisted living residences but still require some degree of medical care or assistance with daily activities; hospice agencies that provides hospice and palliative care; and operates pharmacies, as well as managed care insurance solutions. Further, it offers management, accounting, and financial services; and leases its properties to third party operators. The company was founded in 1971 and is based in Murfreesboro, Tennessee.

Profound Medical stock logo

Profound Medical NASDAQ:PROF

$5.54 +0.09 (+1.65%)
Closing price 08/14/2025 04:00 PM Eastern
Extended Trading
$5.50 -0.04 (-0.72%)
As of 08/14/2025 04:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.

Instil Bio stock logo

Instil Bio NASDAQ:TIL

$28.25 +1.28 (+4.75%)
Closing price 08/14/2025 04:00 PM Eastern
Extended Trading
$28.04 -0.20 (-0.73%)
As of 08/14/2025 07:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Instil Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies. The company develops cell therapy of tumor infiltrating lymphocyte (TIL) for the treatment of cancer. It is developing early-stage pipeline of CoStAR-TIL and other novel TIL technologies. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.